117 related articles for article (PubMed ID: 3129443)
1. Sustained effects of opioid antagonism during the normal human luteal phase.
Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic opioid antagonism on gonadotrophin and ovarian sex steroid secretion during the luteal phase.
Rossmanith WG; Monn M; Benz R
Clin Endocrinol (Oxf); 1998 Sep; 49(3):343-51. PubMed ID: 9861326
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
Vermesh M; Kletzky OA
J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
[TBL] [Abstract][Full Text] [Related]
4. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
5. The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women.
Maruncic M; Casper RF
J Clin Endocrinol Metab; 1987 Jan; 64(1):148-52. PubMed ID: 3782428
[TBL] [Abstract][Full Text] [Related]
6. [Pulsatile secretion of prolactin during the human menstrual cycle].
Masaoka K; Kitazawa M; Niibe T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1793-9. PubMed ID: 3209907
[TBL] [Abstract][Full Text] [Related]
7. Regulation of pulsatile secretion of progesterone during the human luteal phase.
Steele PA; Braund W; Judd SJ
Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
[TBL] [Abstract][Full Text] [Related]
8. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
Braund W; Roeger DC; Judd SJ
J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.
Filicori M; Butler JP; Crowley WF
J Clin Invest; 1984 Jun; 73(6):1638-47. PubMed ID: 6427277
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
[TBL] [Abstract][Full Text] [Related]
11. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
Van Vugt DA; Lam NY; Ferin M
Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
[TBL] [Abstract][Full Text] [Related]
12. Prolonged opioid blockade does not influence luteinizing hormone modifications of the follicular and luteal menstrual phases.
Cagnacci A; Paoletti AM; Soldani R; Tuveri F; Melis GB
J Clin Endocrinol Metab; 1995 Mar; 80(3):860-3. PubMed ID: 7883843
[TBL] [Abstract][Full Text] [Related]
13. Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns.
Soules MR; Clifton DK; Cohen NL; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1989 Oct; 69(4):813-20. PubMed ID: 2506215
[TBL] [Abstract][Full Text] [Related]
14. The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration.
Fulghesu AM; Lanzone A; Apa R; Guido M; Ciampelli M; Cucinelli F; Caruso A; Mancuso S
J Endocrinol Invest; 1997; 20(7):368-73. PubMed ID: 9309533
[TBL] [Abstract][Full Text] [Related]
15. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
16. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
17. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
Caufriez A; Leproult R; L'Hermite-Balériaux M; Moreno-Reyes R; Copinschi G
Clin Endocrinol (Oxf); 2009 Oct; 71(4):535-42. PubMed ID: 19222493
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
Matera C; Freda PU; Ferin M; Wardlaw SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
[TBL] [Abstract][Full Text] [Related]
19. Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates.
Van Vugt DA; Heisler LE; Reid RL
J Clin Endocrinol Metab; 1992 Jun; 74(6):1312-9. PubMed ID: 1592876
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile secretion of prolactin and luteinizing hormone and their synchronous relationship during the human menstrual cycle.
Masaoka K; Kitazawa M; Kumasaka T
Gynecol Endocrinol; 1988 Dec; 2(4):293-303. PubMed ID: 3232553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
